Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: Implication in the migration

Proteomics

Volumn 9, Issue 1, 2009, Pages 20-30

  Li, Guo ^a   Zhang, Xiao Ai ^a   Wang, Hua ^a   Wang, Xin ^a   Meng, Chun Ling ^a   Chan, Chu Yan ^a   Yew, David Tai Wai ^a   Tsang, Kam Sze ^a   Li, Karen ^a   Tsai, Sau Na ^a   Ngai, Sai Ming ^a   Han, Zhong Chao ^b   Lin, Marie Chia Mi ^c   He, Ming Liang ^a   Kung, Hsiang Fu ^a,d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bone marrow; Mesenchymal stem cells; Migration; Placenta; Umbilical cord

Indexed keywords

CATHEPSIN B; CATHEPSIN D; MANGANESE SUPEROXIDE DISMUTASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROHIBITIN; PROTEOME; SERPINE1 PROTEIN, HUMAN;

ARTICLE; BONE MARROW; CELL FUNCTION; CELL INVASION; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MASS SPECTROMETRY; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REGENERATION; TISSUE REGENERATION; TISSUE REPAIR; TWO DIMENSIONAL ELECTROPHORESIS; UMBILICAL CORD; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CHEMISTRY; CYTOLOGY; FEMALE; GENE SILENCING; METABOLISM;

BONE MARROW CELLS; CATHEPSIN B; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; PLACENTA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOME; UMBILICAL CORD;

EID: 59449100237     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200701195     Document Type: Article

References (38)

1. Panepucci, R. A., Siufi, J. L., Silva, W. A., Jr., Proto-Siquiera, R. et al., Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004, 22, 1263-1278.
2. Musina, R. A., Bekchanova, E. S., Belyavskii, A. V., Sukhikh, G. T., Differentiation potential of mesenchymal stem cells of different origin. Bull Exp. Bio.l Med. 2006, 141, 147-151.
3. Miao, Z., Jin, J., Chen, L., Zhu, J. et al., Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells. Cell Biol. Int. 2006, 30, 681-687.
4. Lu, L. L., Liu, Y. J., Yang, S. G., Zhao, Q. J. et al., Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006, 97, 1017-1026.
5. Hordijk, P., Endothelial signaling in leukocyte transmigration. Cell Biochem. Biophys. 2003, 38, 305-322.
6. Nourshargh, S., Marelli-Berg, F. M., Transmigration through venular walls: A key regulator of leukocyte phenotype and function. Trends Immunol. 2005, 26, 157-165.
7. Schmidt, A., Ladage, D., Steingen, C., Brixius, K. et al., Mes- enchymal stem cells transmigrate over the endothelial barrier. Eur. J. Cell Biol. 2006, 85, 1179-1188.
8. Zhu, H., Mitsuhashi, N., Klein, A., Barsky, L. W. et al., The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 2006, 24, 928-935.
9. Lopez Ponte, A., Marais, E., Gallay, N., Langonne, A. et al., The in vitro migration c apacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25, 1737-1745.
10. Son, B. R., Marquez-Curtis, L. A., Kucia, M., Wysoczynski, M. et al., Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by SDF-1-CXCR4 and HGF-c-met axes and involves matrix metalloproteinases. Stem Cells 2006, 24, 1254-1264.
11. De Becker, A., Van Hummelen, P., Bakkus, M., Vande Broek, I. et al., Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metal- loproteinase-3. Haematologica 2007, 92, 440-449.
12. Neth, P., Ciccarella, M., Egea, V., Hoelters, J. et al., Wnt Signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells 2006, 24, 1892-1903.
13. Ding, S. J., Li, Y., Tan, Y. X., Jiang, M. R. et al., From prote- omic analysis to clinical significance: Overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol. Cell. Proteomics 2004, 3, 73-81.
14. Lee, H. K., Lee, B. H., Park, S. A., Kim, C. W., The proteomic analysis of an adipocyte differentiated from human mesen- chymal stem cells using two-dimensional gel electrophore- sis. Proteomics 2006, 6, 1223-1229.
15. Lund, R. D., Wang, S., Lu, B., Girman, S. et al., Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2007, 25, 602-611.
16. Weiss, M. L., Medicetty, S., Bledsoe, A. R., Rachakatla, R. S. et al., Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24, 781-792.
17. Allers, C., Sierralta, W. D., Neubauer, S., Rivera, F. et al.,Dynamic of distribution of human bone marrow-derived mes- enchymal stem cells after transplantation into adult unconditioned mice. Transplantation 2004, 78, 503-508.
18. Bensidhoum, M., Chapel, A., Francois, S., Demarquay, C. et al., Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 2004, 103, 3313-3319.
19. Liechty, K. W., MacKenzie, T. C., Shaaban, A. F., Radu, A. et al., Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. 2000, 6, 1282-1286.
20. Gao, J., Dennis, J. E., Muzic, R. F., Lundberg, M., Caplan, A. I., The dynamic in vivo distribution of bone marrowderived mesenchymal stem cells after infusion. Cells Tissues Organs 2001, 169, 12-20.
21. Halliwell, B., Gutteridge, J. M. C., Free Radicals in Biology and Medicine, Oxford University Press, New York 1986, pp. 86-106.
22. Oberley, L. W., Buettner, G. R., Role of superoxide dismutase in cancer: A review. Cancer Res. 1979, 39, 1141-1149.
23. Safford, S. E., Oberley, T. D., Urano, M., St. Clair, D. K., Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res. 1994, 54, 4261-4265.
24. McClung, J. K., Jupe, E. R., Liu, X. T., Dell'Orco, R. T., Prohi-bitin: Potential role in senescence, development, and tumor suppression. Exp. Gerontol. 1995, 30, 99-124.
25. Rajalingam, K., Wunder, C., Brinkmann, V., Churin, Y. et al., Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat. Cell Biol. 2005, 7, 837843.
26. Aznavoorian, S., Murphy, A. N., Stetler-Stevenson, W. G., Liotta, L. A., Molecular aspects of tumor cell invasion and metastasis. Cancer 1993, 71, 1368-1383.
27. Del Rosso, M., Fibbi, G., Pucci, M., D'Alessio, S. et al., Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin. Exp. Metastasis 2002, 79, 193-207.
28. Egeblad, M., Werb, Z., New functions for the matrix metal- loproteinases in cancer progression. Nat. Rev. Cancer 2002, 2, 161-174.
29. Turk, V., Kos, J., Turk, B., Cysteine cathepsins (proteases)-on the main stage of cancer? Cancer Cell 2004, 5, 409-410.
30. Podgorski, I., Sloane, B. F., Cathepsin B and its role(s) in cancer progression. Biochem. Soc. Symp. 2003, 70, 263-276.
31. Yan, S., Sloane, B. F., Molecular regulation of human ca- thepsin B: Implication in pathologies. Biol. Chem. 2003, 384, 845-854.
32. Vasiljeva, O., Papazoglou, A., Kruger, A., Brodoefel, H. et al., Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res. 2006, 66, 5242-5250.
33. Wickramasinghe, N. S., Nagaraj, N. S., Vigneswaran, N., Zacharias, W., Cathepsin B promotes both motility and invasiveness of oral carcinoma cells. Arch. Biochem. Bio-phys. 2005, 436, 187-195.
34. Oh-e, H., Tanaka, S., Kitadai, Y., Shimamoto, F. et al.,Ca- thepsin D expression as a possible predictor of lymph node metastasis in submucosal colorectal cancer. Eur. J. Cancer 2001, 37, 180-188.
35. Ikeguchi, M., Fukuda, K., Oka, S., Hisamitsu, K. et al., Micro- lymph node metastasis and its correlation with cathepsin D expression in early gastric cancer. J. Surg. Oncol. 2001, 77, 188-194.
36. Glondu, M., Liaudet-Coopman, E., Derocq, D., Platet, N. et al., Down-regulation ofcathepsin-D expression byantisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Oncogene 2002, 27, 5127-5134.
37. Praus, M., Collen, D., Gerard, R. D., Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis. Int. J. Cancer 2002, 102, 584-591.
38. Lim, I. T., Meroueh, S. O., Lee, M., Heeg, M. J., Mobashery, S., Strategy in inhibition of cathepsin B, a target in tumor invasion and metastasis. J. Am. Chem. Soc. 2004, 726, 10271-10277.